Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

The singer shared that she was dropped by her record label for "being too fat" and confessed, "I thought I needed Ozempic to ...

Weight-loss drug developer Metsera is targeting an up to $1.78 billion valuation in its initial public offering, the ARCH Venture Partners-backed biotech company said on Monday. New York City-based ...

Much loved stand-up star, Peter Kay, looked almost unrecognisable today when he was papped in an ultra rare sighting ...

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were takin Wegovy ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Gypsy-Rose Blanchard and Ken Urker went out for their first date night as parents over the weekend. On Sunday, Jan. 26, ...

The ITV star unveiled a simple Mediterranean-style omelette recipe just last year - and it's brimming with several delicious ingredients ...

Leading nutritionists reveal why the viral coffee loophole diet may be damaging your metabolism and what you should do ...

A NEW quiz reveals what your insides could look like based on your lifestyle. The detailed tool, which has been developed with Dr Crystal Wyllie, looks at everything from water and alcohol intake ...

Lizzo will never be “considered thin” — even after losing weight. The Grammy-winning artist’s candid discussion comes amid ...

Weight-loss drug developer Metsera on Monday said it was is targeting to raise as much as $292.2 million in an initial public offering.